Cisplatin and etoposide in oesophageal cancer: a phase II study

This publication has 28 references indexed in Scilit:

• Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus
  JNCI Journal of the National Cancer Institute, 1994
• Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung
  European Journal Of Cancer, 1993
• Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus
  Cancer Chemotherapy and Pharmacology, 1992
• Etoposide and Cisplatin in Advanced Esophageal Cancer: A preliminary report
  Acta Oncologica, 1988
• Evaluation of Response to Preoperative Chemotherapy in Esophageal and Gastric Cardia Cancer Using Biphasic Esophagrams and Surgical-Pathologic Correlation
  American Journal of Clinical Oncology, 1986
• PHASE-II EVALUATION OF CISPLATIN, BLEOMYCIN, AND VINDESINE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
  1986
• Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
  Journal of Biological Chemistry, 1984
• ROLE OF TOPOISOMERASE-II IN MEDIATING EPIPODOPHYLLOTOXIN-INDUCED DNA CLEAVAGE
  1984
• Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma
  The American Journal of Medicine, 1983
• Etoposide—chemistry, preclinical and clinical pharmacology
  Cancer Treatment Reviews, 1982